Study details
Enrolling now
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
University of Louisville
NCT IDNCT00682032ClinicalTrials.gov data as of Apr 2026
Target enrollment
300
Study length
about 20 years
Ages
18+
Locations
1 site in KY
What this study is about
Researchers are testing whether beta-glucan can affect the immune system in people with non-small cell lung cancer. The trial will examine how beta-glucan, a dietary supplement extracted from yeast, influences the body's ability to fight cancer cells.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Beta-glucan
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Oncology